185 related articles for article (PubMed ID: 22018908)
21. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
Poen AC; Otten MH
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
[TBL] [Abstract][Full Text] [Related]
22. Deprescribing proton pump inhibitors: why, when and how.
Bytzer P
Med J Aust; 2018 Nov; 209(10):436-438. PubMed ID: 30404592
[No Abstract] [Full Text] [Related]
23. Treatment of gastroesophageal reflux disease.
Fass R; Bautista J; Janarthanan S
Clin Cornerstone; 2003; 5(4):18-29; discussion 30-1. PubMed ID: 15101492
[TBL] [Abstract][Full Text] [Related]
24. Crying and spilling--time to stop the overmedicalisation of normal infant behaviour.
Hudson B; Alderton A; Doocey C; Nicholson D; Toop L; Day AS
N Z Med J; 2012 Dec; 125(1367):119-26. PubMed ID: 23321888
[TBL] [Abstract][Full Text] [Related]
25. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
26. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter?
Schnoll-Sussman F; Katz PO
Aliment Pharmacol Ther; 2015 Sep; 42(5):626. PubMed ID: 26238577
[No Abstract] [Full Text] [Related]
27. Treatment patterns and symptom control in patients with GERD: US community-based survey.
Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends.
Cooper GS; Mourad WA; Koroukian SM
Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):21-7. PubMed ID: 14971119
[TBL] [Abstract][Full Text] [Related]
29. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
Lamers CB
Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
[TBL] [Abstract][Full Text] [Related]
30. Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.
Biswas S; Benedict SH; Lynch SG; LeVine SM
BMC Med; 2012 Jun; 10():57. PubMed ID: 22676575
[TBL] [Abstract][Full Text] [Related]
31. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter? Authors' reply.
Lødrup A; Pottegård A; Hallas J; Bytzer P
Aliment Pharmacol Ther; 2015 Sep; 42(5):627. PubMed ID: 26238578
[No Abstract] [Full Text] [Related]
32. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
[TBL] [Abstract][Full Text] [Related]
34. Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?
Chung EY; Yardley J
Hosp Pediatr; 2013 Jan; 3(1):16-23. PubMed ID: 24319831
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor utilization patterns in infants.
Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
[TBL] [Abstract][Full Text] [Related]
36. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
Kashin SV; Ivanikov IO
Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
[TBL] [Abstract][Full Text] [Related]
37. Rebound acid hypersecretion.
Porro GB
Scand J Gastroenterol; 2010 Apr; 45(4):387-8. PubMed ID: 20302534
[No Abstract] [Full Text] [Related]
38. Bone up on proton pump inhibitors and fracture risk.
Gendreau-Webb R
Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
[No Abstract] [Full Text] [Related]
39. Acid inhibition and infections outside the gastrointestinal tract.
Vakil N
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S17-20. PubMed ID: 19262541
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic strategies for treating gastroesophageal reflux disease.
Vivian EM; Thompson MA
Clin Ther; 2000 Jun; 22(6):654-72. PubMed ID: 10929915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
